Loading…
Company issued a statement on October 24, 2025.
Theriva Biologics, Inc. (NYSE American: TOVX) issued a statement on October 24, 2025, addressing unusual trading activity observed in its common stock. The company clarified that it is not aware of any specific corporate developments that would account for the recent trading patterns.
As of the latest available data, Theriva Biologics has a free float of 32,990,300 shares and 33,739,600 shares outstanding.
This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.